BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17354235)

  • 1. Six-month natural history of oral versus cervical human papillomavirus infection.
    D'Souza G; Fakhry C; Sugar EA; Seaberg EC; Weber K; Minkoff HL; Anastos K; Palefsky JM; Gillison ML
    Int J Cancer; 2007 Jul; 121(1):143-50. PubMed ID: 17354235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women.
    Fakhry C; D'souza G; Sugar E; Weber K; Goshu E; Minkoff H; Wright R; Seaberg E; Gillison M
    J Clin Microbiol; 2006 Dec; 44(12):4479-85. PubMed ID: 17021055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clearance of oral high-risk human papillomavirus infection is impaired by long-term persistence of cervical human papillomavirus infection.
    Louvanto K; Rautava J; Syrjänen K; Grénman S; Syrjänen S
    Clin Microbiol Infect; 2014 Nov; 20(11):1167-72. PubMed ID: 24890849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral human papillomavirus infection in women with cervical HPV infection: new data from an Italian cohort and a metanalysis of the literature.
    Termine N; Giovannelli L; Matranga D; Caleca MP; Bellavia C; Perino A; Campisi G
    Oral Oncol; 2011 Apr; 47(4):244-50. PubMed ID: 21429788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical and oral human papillomavirus types in HIV-1 positive and negative women with cervical disease in South Africa.
    Marais DJ; Passmore JA; Denny L; Sampson C; Allan BR; Williamson AL
    J Med Virol; 2008 Jun; 80(6):953-9. PubMed ID: 18428143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of human papillomavirus infections involving anal, penile, and oral sites among HIV-positive men.
    Videla S; Darwich L; Cañadas MP; Coll J; Piñol M; García-Cuyás F; Molina-Lopez RA; Cobarsi P; Clotet B; Sirera G;
    Sex Transm Dis; 2013 Jan; 40(1):3-10. PubMed ID: 23250297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study.
    Goodman MT; Shvetsov YB; McDuffie K; Wilkens LR; Zhu X; Thompson PJ; Ning L; Killeen J; Kamemoto L; Hernandez BY
    Cancer Res; 2008 Nov; 68(21):8813-24. PubMed ID: 18974124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Human Papillomavirus Infection and Oral Lesions in HIV-Positive and HIV-Negative Dental Patients.
    Muller K; Kazimiroff J; Fatahzadeh M; Smith RV; Wiltz M; Polanco J; Grossberg RM; Belbin TJ; Strickler HD; Burk RD; Schlecht NF
    J Infect Dis; 2015 Sep; 212(5):760-8. PubMed ID: 25681375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral and cervical HPV infection in HIV-positive and HIV-negative women attending a sexual health clinic in São Paulo, Brazil.
    Lima MD; Braz-Silva PH; Pereira SM; Riera C; Coelho AC; Gallottini M
    Int J Gynaecol Obstet; 2014 Jul; 126(1):33-6. PubMed ID: 24792407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral human papillomavirus infection in HIV-negative and HIV-infected MSM.
    Mooij SH; Boot HJ; Speksnijder AG; Stolte IG; Meijer CJ; Snijders PJ; Verhagen DW; King AJ; de Vries HJ; Quint WG; van der Sande MA; Schim van der Loeff MF
    AIDS; 2013 Aug; 27(13):2117-28. PubMed ID: 24384590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women.
    Williams AB; Darragh TM; Vranizan K; Ochia C; Moss AR; Palefsky JM
    Obstet Gynecol; 1994 Feb; 83(2):205-11. PubMed ID: 8290181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral human papillomavirus (HPV) prevalence in youth and cervical HPV prevalence in women attending a youth clinic in Sweden, a follow up-study 2013-2014 after gradual introduction of public HPV vaccination.
    Grün N; Ährlund-Richter A; Franzén J; Mirzaie L; Marions L; Ramqvist T; Dalianis T
    Infect Dis (Lond); 2015 Jan; 47(1):57-61. PubMed ID: 25378085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV oral lesions in HIV-infected patients: the impact of long-term HAART.
    Anaya-Saavedra G; Flores-Moreno B; García-Carrancá A; Irigoyen-Camacho E; Guido-Jiménez M; Ramírez-Amador V
    J Oral Pathol Med; 2013 Jul; 42(6):443-9. PubMed ID: 23278731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
    Palefsky JM; Holly EA; Ralston ML; Da Costa M ; Greenblatt RM
    J Infect Dis; 2001 Feb; 183(3):383-91. PubMed ID: 11133369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and multiplicity of human papillomavirus infection in HIV-1 positive women in Italy.
    Garbuglia AR; Piselli P; Lapa D; Sias C; Del Nonno F; Baiocchini A; Cimaglia C; Agresta A; Capobianchi MR
    J Clin Virol; 2012 Jun; 54(2):141-6. PubMed ID: 22437054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults.
    Beachler DC; Weber KM; Margolick JB; Strickler HD; Cranston RD; Burk RD; Wiley DJ; Minkoff H; Reddy S; Stammer EE; Gillison ML; D'Souza G
    Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):122-33. PubMed ID: 22045700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of cervical and oral human papillomavirus infections among US women.
    Steinau M; Hariri S; Gillison ML; Broutian TR; Dunne EF; Tong ZY; Markowitz LE; Unger ER
    J Infect Dis; 2014 Jun; 209(11):1739-43. PubMed ID: 24319284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of medication use with clearance or persistence of oral HPV infection.
    Lam JO; Sugar EA; Cranston RD; Weber KM; Burk RD; Wiley DJ; Reddy S; Margolick JB; Strickler HD; Wentz A; Jacobson L; Coles CL; Bream JH; Rositch AF; Guo Y; Xiao W; Gillison ML; D'Souza G
    Cancer Causes Control; 2016 Dec; 27(12):1491-1498. PubMed ID: 27804058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of human papillomavirus types 6, 11, 16, 18, 31, and 33 in a cohort of Greek women.
    Panotopoulou E; Tserkezoglou A; Kouvousi M; Tsiaousi I; Chatzieleftheriou G; Daskalopoulou D; Magiakos G
    J Med Virol; 2007 Dec; 79(12):1898-905. PubMed ID: 17935171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.